FDA Inspection
Oklahoma Blood Institute Texas Blood InstituteOklahoma Blood Institute Texas Blood Institute – FDA Inspection, Apr 22, 2022
Record Details
This FDA Inspection record concerns Oklahoma Blood Institute Texas Blood Institute, with an inspection on April 22, 2022, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- April 22, 2022
- Product Type
- Biologics
View Company Profile
ID · d68fcfce-8881-43c3-8077-d6b583357a49
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1168570
- FDA center
- Biologics
- Project area
- Vaccines and Allergenic Products
Other FDA inspections of Oklahoma Blood Institute Texas Blood Institute
4| Date | Classification | Office | Project area |
|---|---|---|---|
| September 22, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 4, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 5, 2011 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 12, 2009 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Oklahoma Blood Institute Texas Blood Institute
- FDA Inspection 1027102 - 2017-09-22
- FDA Inspection 858221 - 2013-12-04
- FDA Inspection 728160 - 2011-05-05
- FDA Inspection 604725 - 2009-08-12
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.